Event

Significant progress has been made in the management of idiopathic pulmonary fibrosis (IPF). While the 2011 and 2015 evidence based guidelines have empowered clinicians and patients to make informed decisions regarding diagnosis and treatment, significant controversies exists. The goal of this session is to surface controversies frequently encountered in routine clinical practice. The session will be in the format of four Pro/Con provocative debates between experts that will give attendees increased insight into the management of IPF.